<unk>  is contraindicated for individuals using monoamine oxidase inhibitors (e.g., phenelzine, and tranylcypromine), or individuals with agitation, tics, glaucoma, or a hypersensitivity to any ingredients contained in<unk>  pharmaceuticals. Pregnant women are advised to only use the medication if the benefits outweigh the potential risks. Not enough human studies have been conducted to conclusively demonstrate an effect of<unk>  on fetal development. In 2018, a review concluded that it has not been teratogenic in rats and rabbits, and that it "is not a major human teratogen".
Methylphenidate
Dexmethylphenidate
Ethylphenidate
Atomoxetine
Guanfacine
Psychotherapy
Imipramine
Fluoxetine